What do We Learn from the 2016 American College of Cardiology Expert Consensus Decision Pathway on Nonstatin Therapies for Low-Density Lipoprotein-cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk? | Zendy

AI Assistant Blog Pricing

Open Access

What do We Learn from the 2016 American College of Cardiology Expert Consensus Decision Pathway on Nonstatin Therapies for Low-Density Lipoprotein-cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk?

Author(s) -

Yifang Guo

Publication year - 2016

Publication title -

cardiology plus

Language(s) - English

Resource type - Journals

eISSN - 2470-752X

pISSN - 2470-7511

DOI - 10.4103/2470-7511.248359

Subject(s) - disease , medicine , atherosclerotic cardiovascular disease , cardiology , cholesterol , intensive care medicine , bioinformatics , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.